Dec 05 2024 31 mins 3
Join us in this expert interview of 2024 PAD guideline Co-Author Dr. Van de Water (Maastricht) and 2023 ZILVERPASS Author Dr. Bosiers (Bern) in this timely debate.
References:
- Bosiers M, De Donato G, Torsello G, et al. ZILVERPASS study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal lesions. J Cardiovasc Surg. 2023. https://doi.org/10.23736/S0021- 9509.23.12607
- RJ Vossen, TM Fokkema, AC Vahl, and R Balm. Systematic review and meta-analysis comparing the autogenous vein bypass versus a prosthetic graft for above-the-knee femoropopliteal bypass surgery in patients with intermittent claudication. Vascular. Sept 6 2022. Vol 32 issue 1.
- Maxime Dubosq-Lebaz , Audrey Fels , Gilles Chatellier , Yann Gouëffic Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm. J Endovasc Ther. 2023 Sep 30:15266028231202709.
- Alik Farber et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia (BEST-CLI). N Engl J Med. 2022 Dec 22;387(25):2305-2316.
- Andrew W Bradbury et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023 May 27;401(10390):1798-1809.
- Nordanstig et al. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg (2024) 67, 9e96)References:
- Bosiers M, De Donato G, Torsello G, et al. ZILVERPASS study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal lesions. J Cardiovasc Surg. 2023. https://doi.org/10.23736/S0021- 9509.23.12607
- RJ Vossen, TM Fokkema, AC Vahl, and R Balm. Systematic review and meta-analysis comparing the autogenous vein bypass versus a prosthetic graft for above-the-knee femoropopliteal bypass surgery in patients with intermittent claudication. Vascular. Sept 6 2022. Vol 32 issue 1.
- Maxime Dubosq-Lebaz , Audrey Fels , Gilles Chatellier , Yann Gouëffic Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm. J Endovasc Ther. 2023 Sep 30:15266028231202709.
- Alik Farber et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia (BEST-CLI). N Engl J Med. 2022 Dec 22;387(25):2305-2316.
- Andrew W Bradbury et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023 May 27;401(10390):1798-1809.
- Nordanstig et al. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg (2024) 67, 9e96)
